AllNewsPhotosVideos
Encorafenib

Encora

Encora, Latest News

Encorafenib, sold under the brand name Braftovi, is a medication for the treatment of certain melanoma cancers. It is a small molecule BRAF inhibitor that targets key enzymes in the MAPK signaling pathway.
Read More
Encora earns top ranking in Great Place to Work India's 2023 Best Companies to Work - Hindi News | Encora earns top ranking in Great Place to Work India's 2023 Best Companies to Work | Latest business News at Lokmatnews.in

Business :Encora earns top ranking in Great Place to Work India's 2023 Best Companies to Work

PRNewswire Scottsdale (Arizona) [US], June 21: Encora, a global next-gen product engineering provider, today announced its offices in India ... ...

Encora ranks among Top 25 in 2022 India's Best Workplaces in IT & IT-Business Process Management - Hindi News | Encora ranks among Top 25 in 2022 India's Best Workplaces in IT & IT-Business Process Management | Latest business News at Lokmatnews.in

Business :Encora ranks among Top 25 in 2022 India's Best Workplaces in IT & IT-Business Process Management

Encora, a global next-gen product engineering provider, today announced its offices in India have been named among the top 25 workplaces by Great Place to Work® India in the Information Technology (IT) and Information Technology and Business Process ...